Inscrição na biblioteca: Guest
Journal of Environmental Pathology, Toxicology and Oncology

Publicou 4 edições por ano

ISSN Imprimir: 0731-8898

ISSN On-line: 2162-6537

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.4 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.8 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.5 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00049 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.59 SJR: 0.429 SNIP: 0.507 CiteScore™:: 3.9 H-Index: 49

Indexed in

A Pilot Study of Male Breast Cancer in the Veterans Affairs Healthcare System

Volume 29, Edição 3, 2010, pp. 235-244
DOI: 10.1615/JEnvironPatholToxicolOncol.v29.i3.60
Get accessGet access

RESUMO

Background: We report our findings on a hospital-based retrospective pilot cohort with case-controls study, which we carried out to examine genetic, environmental, and occupational risk factors in men with breast cancer. Methods: 86 men with breast cancer were diagnosed in eight VA medical centers that agreed to collaborate on this project. A case-control analysis was conducted on a subset of the male breast cancer cases (n = 44) and age- and ethnicity-matched controls (n = 77). We compared host characteristics, comorbidities, and medications intake between cases and controls by using Chi-square analysis and Fisher's exact test. Results: The descriptive analysis showed that the majority of veterans with male breast cancer were non-Hispanic white (60%), older than 65 years at diagnosis (56%), and more likely estrogen receptor positive (45%). World War II veterans represented the largest group (22%), followed by the Vietnam era veterans (10%). Thirty-three percent reported a positive family history of cancer, while 18% had another primary cancer diagnosis. Prior alcohol (43%) and tobacco use (56%) was substantial among these patients. Twenty percent of patients were overweight or obese and 55% had comorbid diseases with heart disease being the most prevalent, followed by diabetes mellitus. The case-control analysis yielded a significantly greater proportion of cases with gynecomastia (p < 0.0001), a positive family history of cancer (p = 0.0028), history of antibiotic use (p = 0.0112), and history of tobacco use (p = 0.0143) compared to controls. Conclusion: The findings of this hospital-based pilot study indicate case-control differences in gynecomastia and family history of cancer. The pilot study lacked sufficient power to determine a true association between the variables of interest and warrants a large-scale collaborative study between the VA medical centers.

CITADO POR
  1. Ruddy K.J., Winer E.P., Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship, Annals of Oncology, 24, 6, 2013. Crossref

  2. Fentiman Ian, Risk Factors, in Male Breast Cancer, 2017. Crossref

  3. Mikó Edit, Vida András, Kovács Tünde, Ujlaki Gyula, Trencsényi György, Márton Judit, Sári Zsanett, Kovács Patrik, Boratkó Anita, Hujber Zoltán, Csonka Tamás, Antal-Szalmás Péter, Watanabe Mitsuhiro, Gombos Imre, Csoka Balazs, Kiss Borbála, Vígh László, Szabó Judit, Méhes Gábor, Sebestyén Anna, Goedert James J., Bai Péter, Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness, Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1859, 9, 2018. Crossref

  4. Kovács Tünde, Mikó Edit, Vida András, Sebő Éva, Toth Judit, Csonka Tamás, Boratkó Anita, Ujlaki Gyula, Lente Gréta, Kovács Patrik, Tóth Dezső, Árkosy Péter, Kiss Borbála, Méhes Gábor, Goedert James J., Bai Péter, Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors, Scientific Reports, 9, 1, 2019. Crossref

  5. Kovács Patrik, Csonka Tamás, Kovács Tünde, Sári Zsanett, Ujlaki Gyula, Sipos Adrien, Karányi Zsolt, Szeőcs Dóra, Hegedűs Csaba, Uray Karen, Jankó Laura, Kiss Máté, Kiss Borbála, Laoui Damya, Virág László, Méhes Gábor, Bai Péter, Mikó Edit, Lithocholic Acid, a Metabolite of the Microbiome, Increases Oxidative Stress in Breast Cancer, Cancers, 11, 9, 2019. Crossref

  6. Mikó Edit, Kovács Tünde, Sebő Éva, Tóth Judit, Csonka Tamás, Ujlaki Gyula, Sipos Adrienn, Szabó Judit, Méhes Gábor, Bai Péter, Microbiome—Microbial Metabolome—Cancer Cell Interactions in Breast Cancer—Familiar, but Unexplored, Cells, 8, 4, 2019. Crossref

  7. İğci Abdullah, Tükenmez Mustafa, Özkurt Enver, Male Breast Cancer, in Breast Disease, 2016. Crossref

  8. Igci Abdullah, Tukenmez Mustafa, Özkurt Enver, Male Breast Cancer, in Breast Disease, 2019. Crossref

  9. Zhang Ziying, Tang Haosheng, Chen Peng, Xie Hui, Tao Yongguang, Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome, Signal Transduction and Targeted Therapy, 4, 1, 2019. Crossref

  10. Sári Zsanett, Mikó Edit, Kovács Tünde, Jankó Laura, Csonka Tamás, Lente Gréta, Sebő Éva, Tóth Judit, Tóth Dezső, Árkosy Péter, Boratkó Anita, Ujlaki Gyula, Török Miklós, Kovács Ilona, Szabó Judit, Kiss Borbála, Méhes Gábor, Goedert James J., Bai Péter, Indolepropionic Acid, a Metabolite of the Microbiome, Has Cytostatic Properties in Breast Cancer by Activating AHR and PXR Receptors and Inducing Oxidative Stress, Cancers, 12, 9, 2020. Crossref

  11. Sári Zsanett, Mikó Edit, Kovács Tünde, Boratkó Anita, Ujlaki Gyula, Jankó Laura, Kiss Borbála, Uray Karen, Bai Péter, Indoxylsulfate, a Metabolite of the Microbiome, Has Cytostatic Effects in Breast Cancer via Activation of AHR and PXR Receptors and Induction of Oxidative Stress, Cancers, 12, 10, 2020. Crossref

  12. Cook Michael B., Guénel Pascal, Gapstur Susan M., van den Brandt Piet A., Michels Karin B., Casagrande John T., Cooke Rosie, Van Den Eeden Stephen K., Ewertz Marianne, Falk Roni T., Gaudet Mia M., Gkiokas George, Habel Laurel A., Hsing Ann W., Johnson Kenneth, Kolonel Laurence N., La Vecchia Carlo, Lynge Elsebeth, Lubin Jay H., McCormack Valerie A., Negri Eva, Olsson Håkan, Parisi Dominick, Petridou Eleni Th., Riboli Elio, Sesso Howard D., Swerdlow Anthony, Thomas David B., Willett Walter C., Brinton Louise A., Tobacco and Alcohol in Relation to Male Breast Cancer: An Analysis of the Male Breast Cancer Pooling Project Consortium, Cancer Epidemiology, Biomarkers & Prevention, 24, 3, 2015. Crossref

  13. Kovács Tünde, Mikó Edit, Ujlaki Gyula, Yousef Heba, Csontos Viktória, Uray Karen, Bai Peter, The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer, Cancer and Metastasis Reviews, 40, 4, 2021. Crossref

  14. Filippone Alessio, Magno Stefano, Clinical Connections Between the Microbiota and Breast Cancer (Onset, Progression and Management), in Comprehensive Gut Microbiota, 2022. Crossref

  15. Di Modica Martina, Arlotta Valeria, Sfondrini Lucia, Tagliabue Elda, Triulzi Tiziana, The Link Between the Microbiota and HER2+ Breast Cancer: The New Challenge of Precision Medicine, Frontiers in Oncology, 12, 2022. Crossref

  16. Lerttiendamrong Bhoowit, Vongsaisuwon Mawin, First report of bilateral synchronous male accessory breast cancer, BMJ Case Reports, 15, 8, 2022. Crossref

Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa Políticas de preços e assinaturas Begell House Contato Language English 中文 Русский Português German French Spain